E
Exact Therapeutics AS
OSE:EXTX
Exact Therapeutics AS
OSE:EXTX
Price:
1.9
NOK
Market Closed
Market Cap:
kr120.2m
Income Statement
Earnings Waterfall
Exact Therapeutics AS
Exact Therapeutics AS
Income Statement
Exact Therapeutics AS
Exact Therapeutics AS
Currency: NOK
| Dec-2021 | Jun-2022 | Dec-2022 | Jun-2023 | Dec-2023 | Jun-2024 | Dec-2024 | Jun-2025 | ||
|---|---|---|---|---|---|---|---|---|---|
| Revenue | |||||||||
| Interest Expense |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Revenue |
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
|
| Operating Income | |||||||||
| Operating Expenses |
(59)
|
(49)
|
(40)
|
(36)
|
(48)
|
(55)
|
(51)
|
(67)
|
|
| Selling, General & Administrative |
(18)
|
(6)
|
(14)
|
(20)
|
(22)
|
(22)
|
(23)
|
(28)
|
|
| Research & Development |
0
|
0
|
0
|
0
|
0
|
0
|
(25)
|
(24)
|
|
| Depreciation & Amortization |
(2)
|
(2)
|
(2)
|
(2)
|
(2)
|
(2)
|
(2)
|
(3)
|
|
| Other Operating Expenses |
(39)
|
(41)
|
(24)
|
(15)
|
(23)
|
(31)
|
(1)
|
(12)
|
|
| Operating Income |
(59)
N/A
|
(49)
+18%
|
(40)
+17%
|
(36)
+10%
|
(48)
-32%
|
(55)
-15%
|
(51)
+6%
|
(67)
-31%
|
|
| Pre-Tax Income | |||||||||
| Interest Income Expense |
1
|
(0)
|
0
|
0
|
(0)
|
1
|
1
|
(3)
|
|
| Non-Reccuring Items |
0
|
(0)
|
(0)
|
(0)
|
(1)
|
(1)
|
(1)
|
(1)
|
|
| Total Other Income |
0
|
0
|
0
|
0
|
(0)
|
0
|
(0)
|
(0)
|
|
| Pre-Tax Income |
(59)
N/A
|
(49)
+16%
|
(41)
+18%
|
(36)
+10%
|
(48)
-33%
|
(55)
-14%
|
(52)
+5%
|
(72)
-38%
|
|
| Net Income | |||||||||
| Tax Provision |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Income from Continuing Operations |
(59)
|
(49)
|
(40)
|
(36)
|
(48)
|
(55)
|
(52)
|
(72)
|
|
| Net Income (Common) |
(59)
N/A
|
(49)
+16%
|
(40)
+19%
|
(36)
+10%
|
(48)
-34%
|
(55)
-14%
|
(52)
+5%
|
(72)
-38%
|
|
| EPS (Diluted) |
-1.95
N/A
|
-1.64
+16%
|
-1.34
+18%
|
-1.2
+10%
|
-1.51
-26%
|
-1.72
-14%
|
-1.51
+12%
|
-1.14
+25%
|
|
Switch to:
Switch to:
See Also
Discover More
